| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.058 | 0.3 |